You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ESSDAI

Showing 1 - 25 of 76
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sjögren and Gynecologic Considerations

Completed
  • Primary Sjögren Syndrome
  • +3 more
  • Visual analogue scale (VAS) for dyspareunia
  • +3 more
  • Ankara, Turkey
    Ankara City Hospital
Jan 3, 2023

Sjogren's Syndrome (SS) Trial in Utrecht (Ravaglimab, Ravagalimab, Placebo)

Withdrawn
  • Sjogren's Syndrome (SS)
  • Utrecht, Netherlands
    Universitair Medisch Centrum Utrecht /ID# 214029
Jan 20, 2022

Sjogren's Syndrome, Fatigue, Pain Syndrome Trial in Yildirim (FACT-F questionnaire, Beck Depression Inventory, Beck Anxiety

Completed
  • Sjogren's Syndrome
  • +5 more
  • FACT-F questionnaire
  • +6 more
  • Yıldırım, Bursa, Turkey
    Koray Ayar
Nov 29, 2021

Sjogren's Syndrome Trial (Anifrolumab)

Recruiting
  • Sjogren's Syndrome
  • Groningen, Netherlands
    University Medical Centre Groningen
Dec 16, 2022

Sjogren's Syndrome Trial in Beijing (Baricitinib, Hydroxychloroquine)

Recruiting
  • Sjogren's Syndrome
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 17, 2022

Sjogren's Syndrome Trial (Dazodalibep, Placebo)

Not yet recruiting
  • Sjogren's Syndrome
  • (no location specified)
Oct 23, 2023

Primary Sjögren's Syndrome Trial (Efgartigimod, Placebo)

Not yet recruiting
  • Primary Sjögren's Syndrome
  • Efgartigimod
  • Placebo
  • (no location specified)
Apr 5, 2023

Sjögren's Syndrome Trial in Worldwide (Deucravacitinib, Placebo)

Not yet recruiting
  • Sjögren's Syndrome
  • Santa Monica, California
  • +25 more
Jul 19, 2023

Sjogren's Syndrome Trial in Beijing (Baricitinib 2 MG)

Completed
  • Sjogren's Syndrome
  • Baricitinib 2 MG
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 26, 2021

Sjögren's Syndrome Trial in Worldwide (SAR441344, Placebo)

Recruiting
  • Sjögren's Syndrome
  • DeBary, Florida
  • +38 more
Dec 29, 2022

Primary Sjogren's Syndrome Trial in China (Telitacicept 80 mg, Telitacicept 160 mg, Placebo)

Not yet recruiting
  • Primary Sjogren's Syndrome
  • Telitacicept 80 mg
  • +2 more
  • Bengbu, Anhui, China
  • +67 more
Jan 5, 2023

Sjogren Syndrome With Other Organ Involvement Trial (Hydroxychloroquine, Tacrolimus)

Not yet recruiting
  • Sjogren Syndrome With Other Organ Involvement
  • (no location specified)
Dec 28, 2022

Sjogren's Syndrome Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (tofacitinib, Placebo)

Recruiting
  • Sjogren's Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 24, 2022

Primary Sjögren's Syndrome Trial in Worldwide (S95011 concentrate for solution for infusion, Placebo concentrate for solution

Active, not recruiting
  • Primary Sjögren's Syndrome
  • S95011 concentrate for solution for infusion
  • Placebo concentrate for solution for infusion
  • Beverly Hills, California
  • +27 more
Jan 13, 2023

Sjogren Syndrome With Other Organ Involvement Trial (Prednisolone, Tacrolimus)

Not yet recruiting
  • Sjogren Syndrome With Other Organ Involvement
  • (no location specified)
Jan 12, 2023

Primary Sjogren's Syndrome Trial (LY3361237)

Not yet recruiting
  • Primary Sjogren's Syndrome
  • (no location specified)
Mar 20, 2023

Sjogrens Syndrome Trial (Ianalumab (VAY736), Placebo)

Not yet recruiting
  • Sjogrens Syndrome
  • Ianalumab (VAY736)
  • Placebo
  • (no location specified)
Aug 3, 2023

Intestinal Microbiota in Gougerot-Sjögren Syndrome According to

Recruiting
  • Sjogren's Syndrome
  • Biomarker detection
  • Nîmes, France
    CHU de Nimes
May 24, 2022

Sjogren Syndrome Trial (VAY736, Placebo)

Not yet recruiting
  • Sjogren Syndrome
  • VAY736
  • Placebo
  • (no location specified)
Jul 14, 2022

Sjogren Syndrome Trial (VAY736, Placebo)

Not yet recruiting
  • Sjogren Syndrome
  • VAY736
  • Placebo
  • (no location specified)
Jul 14, 2022

Sjögren's Syndrome Trial in Beijing (low-dose interleukin-2, rapamycin)

Recruiting
  • Sjögren's Syndrome
  • Beijing, Beijing, China
    Peking university people's hospital
Dec 2, 2022

Systemic Lupus Erythematosus Trial in Changchun (IL-2)

Completed
  • Systemic Lupus Erythematosus
  • Changchun, Changchun/Jilin, China
    Sirui Yang
Aug 16, 2022

Sjogren Syndrome, Mixed Connective Tissue Disease Trial in Worldwide (MHV370, Placebo)

Recruiting
  • Sjogren Syndrome
  • Mixed Connective Tissue Disease
  • Guangzhou, Guangdong, China
  • +18 more
Jul 29, 2022

Primary Sjogren's Syndrome Trial in Palo Alto (tibulizumab (LY3090106))

Withdrawn
  • Primary Sjogren's Syndrome
  • tibulizumab (LY3090106)
  • Palo Alto, California
    Stanford University
Jan 12, 2022

SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)

Recruiting
  • SLE (Systemic Lupus)
  • +4 more
  • CD19 targeted CAR-T cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Sep 25, 2023